| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.095 | 0.0007 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0008 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0009 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |